Literature DB >> 17025258

Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: a technical note.

Hamid A Merchant1, Harris M Shoaib, Jaweria Tazeen, Rabia Yousuf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17025258      PMCID: PMC2750520          DOI: 10.1208/pt070378

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


× No keyword cloud information.
  9 in total

1.  MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.

Authors:  T HIGUCHI
Journal:  J Pharm Sci       Date:  1963-12       Impact factor: 3.534

2.  Multiple-layer, direct-compression, controlled-release system: in vitro and in vivo evaluation.

Authors:  R A Fassihi; W A Ritschel
Journal:  J Pharm Sci       Date:  1993-07       Impact factor: 3.534

Review 3.  Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC).

Authors:  J Siepmann; N A Peppas
Journal:  Adv Drug Deliv Rev       Date:  2001-06-11       Impact factor: 15.470

4.  Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist.

Authors:  N Saathoff; H Lode; K Neider; K M Depperman; K Borner; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

5.  Hydroxypropyl methylcellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in vitro release kinetics.

Authors:  Muniyandy Saravanan; Kalakonda Sri Nataraj; Kettavarampalayam Swaminath Ganesh
Journal:  Chem Pharm Bull (Tokyo)       Date:  2003-08       Impact factor: 1.645

6.  Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation.

Authors:  K Raghuram Reddy; Srinivas Mutalik; Srinivas Reddy
Journal:  AAPS PharmSciTech       Date:  2003-12-12       Impact factor: 3.246

7.  Cefpodoxime proxetil: a comprehensive review.

Authors:  W M Todd
Journal:  Int J Antimicrob Agents       Date:  1994-03       Impact factor: 5.283

8.  Once-a-day controlled-release dosage form of divalproex sodium II: development of a predictive in vitro drug release method.

Authors:  Yihong Qiu; J Garren; E Samara; G Cao; C Abraham; H S Cheskin; K R Engh
Journal:  J Pharm Sci       Date:  2003-11       Impact factor: 3.534

9.  In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers.

Authors:  H S Sader; R N Jones; J A Washington; P R Murray; E H Gerlach; S D Allen; M E Erwin
Journal:  Diagn Microbiol Infect Dis       Date:  1993 Aug-Sep       Impact factor: 2.803

  9 in total
  16 in total

1.  A novel synergistic galactomannan-based unit dosage form for sustained release of acarbose.

Authors:  Ruchita V Kumar; Vivek Ranjan Sinha
Journal:  AAPS PharmSciTech       Date:  2012-01-11       Impact factor: 3.246

2.  Development of controlled-release matrix tablet of risperidone: influence of Methocel®- and Ethocel®-based novel polymeric blend on in vitro drug release and bioavailability.

Authors:  Amir Badshah; Fazal Subhan; Khalid Rauf; Nadeem Irfan Bukhari; Kifayatullah Shah; Samiullah Khan; Zia Ahmed; Ihsanullah Khan
Journal:  AAPS PharmSciTech       Date:  2011-04-15       Impact factor: 3.246

3.  Design and evaluation of a novel matrix type multiple units as biphasic gastroretentive drug delivery systems.

Authors:  Meka Lingam; Thadisetty Ashok; Vobalaboina Venkateswarlu; Yamsani Madhusudan Rao
Journal:  AAPS PharmSciTech       Date:  2008-12-31       Impact factor: 3.246

4.  Design of an interpolyelectrolyte gastroretentive matrix for the site-specific zero-order delivery of levodopa in Parkinson's disease.

Authors:  Ndidi C Ngwuluka; Yahya E Choonara; Girish Modi; Lisa C du Toit; Pradeep Kumar; Valence M K Ndesendo; Viness Pillay
Journal:  AAPS PharmSciTech       Date:  2013-03-15       Impact factor: 3.246

5.  Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention.

Authors:  Jianing Meng; Tao Zhang; Vivek Agrahari; Miezan J Ezoulin; Bi-Botti C Youan
Journal:  Nanomedicine (Lond)       Date:  2014-01-10       Impact factor: 5.307

6.  Guar gum, xanthan gum, and HPMC can define release mechanisms and sustain release of propranolol hydrochloride.

Authors:  Muhammad Akhlaq Mughal; Zafar Iqbal; Steven Henry Neau
Journal:  AAPS PharmSciTech       Date:  2010-12-21       Impact factor: 3.246

7.  A menthol-based solid dispersion technique for enhanced solubility and dissolution of sulfamethoxazole from an oral tablet matrix.

Authors:  Bibi F Choonara; Yahya E Choonara; Pradeep Kumar; Lisa C du Toit; Lomas K Tomar; Charu Tyagi; Viness Pillay
Journal:  AAPS PharmSciTech       Date:  2014-12-31       Impact factor: 3.246

8.  Controlled release matrix tablets of olanzapine: influence of polymers on the in vitro release and bioavailability.

Authors:  Amir Badshah; Fazal Subhan; Khalid Rauf
Journal:  AAPS PharmSciTech       Date:  2010-09-08       Impact factor: 3.246

9.  Formulation and evaluation of a protein-loaded solid dispersions by non-destructive methods.

Authors:  Ziyaur Rahman; Ahmed S Zidan; Mansoor A Khan
Journal:  AAPS J       Date:  2010-02-03       Impact factor: 4.009

10.  Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188.

Authors:  Mowafaq M Ghareeb; Alaa A Abdulrasool; Ahmed A Hussein; Mohammed I Noordin
Journal:  AAPS PharmSciTech       Date:  2009-10-28       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.